Skip to main content
OpenTrials
Completed

NCT Number: NCT02454491

Verapamil vs Heparin in Transradial Procedures

Transradial approach (TRA) for cardiac catheterization and percutaneous coronary interventions (PCI) is increasingly being used worldwide. At the present is unknown the cocktail of agents necessary to minimize local access site complications. The investigators planned a prospective randomized clinical trial to test the superiority of verapamil vs. heparin in the reduction of access site related complications.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

University Hospital of Ferrara

Cona, Ferrara, 44124, Italy

About this study

Transradial approach (TRA) for cardiac catheterization and percutaneous coronary interventions (PCI) is increasingly being used worldwide in both elective and emergency procedures because it reduces net adverse clinical events, through a reduction in major bleeding and all-cause mortality, when compared to transfemoral approach. However, radial artery occlusion (RAO) after the procedure (the incidence of which varies from 1% to 10%) remains one of the major limitations of TRA.

The aim of the study is to assess the superiority of verapamil versus heparin in the access success during transradial percutaneous coronary interventions (PCI).

METHODS Patients referred to the cath-lab of the Cardiovascular Institute of the University Hospital of Ferrara, Italy, for coronary angiography were randomized in 2 groups with a computer-generated random sequence. The study is double-blind. In the first group, patients received intravenous heparin (5000 UI) immediately after a 6 F sheath insertion. In the second group, patients received Verapamil (5 mg) immediately after a 6 F sheath insertion. If after the start of the procedure a radial artery spasm (RAS) occurs, the operators can choose to use bail-out a local vasodilator therapy. After sheath removal, hemostasis was obtained using a TR band (Terumo corporation, Tokyo, Japan) with a plethysmography-guided patent hemostasis technique. Radial artery patency was evaluated at 24 hours (early RAO) and 30 days after the procedure (late RAO) by ultrasound.

The aim of the study is to demonstrate that verapamil administration is superior to heparin administration in the reduction of the combined endpoint (occurrence of radial artery occlusion (early RAO), access site complication, radial artery spasm (RAS) requiring local bailout use of vasodilatator)

RAO will be assessed by ultrasonography by independent expert reviewer blinded to randomization

The investigators defined access site complication the following items:

  • local haematoma superficial <5 cm from access site;
  • haematoma with moderate muscle infiltration <10 cm;
  • forearm haematoma and muscular infiltration below the elbow;
  • haematoma and muscular infiltration above the elbow;
  • ischemic threat (compartmental syndrome);
  • radial artery dissection during the procedure;

The investigators defined radial artery spasm any spasm occurring during the procedure requiring the administration of local vasodilatators to allow the procedure

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients admitted to hospital with diagnosis of acute coronary syndrome and stable coronary artery disease according current European guidelines and with clinical indication to coronary artery angiography.

  • all patients receiving percutaneous coronary intervention by radial artery access as first attempt
  • procedures with 6F catheter

Exclusion criteria

  • warfarin therapy
  • previous ipsilateral TRA
  • lack of consent
  • scleroderma
  • thrombocytopenia
  • or other contraindications to heparin

Treatment and study plan

Heparin

Drug

intraradial administration of heparin 5000 ui

Verapamil

Drug

intraradial administration of verapamil 5 mg

Primary outcomes

  1. number of participants with radial artery-related complications

    Time frame: 24 hours

    occurrence of early radial artery occlusion, access site complication, radial artery spasm (RAS) that requires the bailout use of vasodilatator

Secondary outcomes

  1. number of participants with each radial artery-related complication

    Time frame: 24 hours

    occurrence of each singular component of primary endpoint

  2. late radial artery occlusion

    Time frame: 30 days

    occurrence of radial artery occlusion (late RAO)

  3. reopening early RAO

    Time frame: 30 days

    reopening of the closed radial at 24 hours.

  4. patient's satisfaction

    Time frame: 24 hours

    assessment with questionnaires of the pain and satisfaction of patients

  5. long term patient's satisfaction

    Time frame: 30 days

    assessment with questionnaires of the pain and satisfaction of patients

Sponsors and collaborators

Lead sponsor

University Hospital of Ferrara

Other

Registry information

Official study title

Comparison of VERapamil vs. Heparin Therapy on Procedural sUccess During Transradial Coronary Procedures (VERMUT Study)

Acronym: VERMUT

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
May 27, 2015
Registry last updated
Oct 4, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.